Cite
EP1.12-18 NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
MLA
Ramirez, R., et al. “EP1.12-18 NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System.” Journal of Thoracic Oncology, vol. 14, no. 10, Number 10 Supplement 1, Oct. 2019, p. S1023. EBSCOhost, https://doi.org/10.1016/j.jtho.2019.08.2263.
APA
Ramirez, R., Matrana, M., Satti, S., Griffin, R., Voros, B., Mohammed, A., Thiagarajan, R., Boudreaux, J. P., & Woltering, E. (2019). EP1.12-18 NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System. Journal of Thoracic Oncology, 14(10, Number 10 Supplement 1), S1023. https://doi.org/10.1016/j.jtho.2019.08.2263
Chicago
Ramirez, R., M. Matrana, S. Satti, R. Griffin, B. Voros, A. Mohammed, R. Thiagarajan, J.P. Boudreaux, and E. Woltering. 2019. “EP1.12-18 NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System.” Journal of Thoracic Oncology 14 (10, Number 10 Supplement 1): S1023. doi:10.1016/j.jtho.2019.08.2263.